1. Home
  2. KF vs CNXU Comparison

KF vs CNXU Comparison

Compare KF & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korea Fund Inc. (The) New

KF

Korea Fund Inc. (The) New

HOLD

Current Price

$73.70

Market Cap

272.5M

Sector

Finance

ML Signal

HOLD

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$10.78

Market Cap

282.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KF
CNXU
Founded
1984
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.5M
282.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KF
CNXU
Price
$73.70
$10.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.2K
47.0K
Earning Date
01-01-0001
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.38
$9.79
52 Week High
$81.94
$13.64

Technical Indicators

Market Signals
Indicator
KF
CNXU
Relative Strength Index (RSI) 51.13 N/A
Support Level $63.17 N/A
Resistance Level $78.87 N/A
Average True Range (ATR) 3.70 0.00
MACD -0.57 0.00
Stochastic Oscillator 41.76 0.00

Price Performance

Historical Comparison
KF
CNXU

About KF Korea Fund Inc. (The) New

Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and Others.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: